Christopher A. McGinnis

CIK: 0001652479

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (33.3%)

Derivative conversions

Awards (A)4 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GDRX

GoodRx Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

GDRX
GoodRx Holdings, Inc.
Jul 15, 2026
Exercise(M)
Direct
37K shares-
GDRX
GoodRx Holdings, Inc.
Jul 15, 2026
Tax Payment(F)
Direct
16.3K shares at avg. $3.01$49K
GDRX
GoodRx Holdings, Inc.
May 15, 2026
Exercise(M)
Direct
44.8K shares-
GDRX
GoodRx Holdings, Inc.
May 15, 2026
Tax Payment(F)
Direct
19.7K shares at avg. $2.49$49K
GDRX
GoodRx Holdings, Inc.
Apr 15, 2026
Exercise(M)
Restricted Stock Unit
Direct
37K shares-
GDRX
GoodRx Holdings, Inc.
Apr 15, 2026
Award(A)
Direct
37K shares-
GDRX
GoodRx Holdings, Inc.
Apr 15, 2026
Tax Payment(F)
Direct
10.7K shares at avg. $2.23$24K
GDRX
GoodRx Holdings, Inc.
Mar 3, 2026
Award(A)
Restricted Stock Unit
Direct
443.9K shares-
GDRX
GoodRx Holdings, Inc.
Feb 15, 2026
Exercise(M)
Direct
179.1K shares-
GDRX
GoodRx Holdings, Inc.
Feb 15, 2026
Tax Payment(F)
Direct
52.8K shares at avg. $2.18$115K
GDRX
GoodRx Holdings, Inc.
Mar 3, 2025
Award(A)
Restricted Stock Unit
Direct
716.5K shares-
GDRX
GoodRx Holdings, Inc.
Mar 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.1M shares-

		Type	Shares	Price		Ownership
Jul 15, 2026	GDRX GoodRx Holdings, Inc.	Exercise(M)	36,988	-	$0	Direct
Jul 15, 2026	GDRX GoodRx Holdings, Inc.	Tax Payment(F)	16,294	$3.01	$49,045	Direct
May 15, 2026	GDRX GoodRx Holdings, Inc.	Exercise(M)	44,779	-	$0	Direct
May 15, 2026	GDRX GoodRx Holdings, Inc.	Tax Payment(F)	19,726	$2.49	$49,118	Direct
Apr 15, 2026	GDRX GoodRx Holdings, Inc.	Exercise(M) Restricted Stock Unit	36,987	-	-	Direct
Apr 15, 2026	GDRX GoodRx Holdings, Inc.	Award(A)	36,987	-	$0	Direct
Apr 15, 2026	GDRX GoodRx Holdings, Inc.	Tax Payment(F)	10,745	$2.23	$23,961	Direct
Mar 3, 2026	GDRX GoodRx Holdings, Inc.	Award(A) Restricted Stock Unit	443,852	-	-	Direct
Feb 15, 2026	GDRX GoodRx Holdings, Inc.	Exercise(M)	179,120	-	$0	Direct
Feb 15, 2026	GDRX GoodRx Holdings, Inc.	Tax Payment(F)	52,799	$2.18	$115,102	Direct
Mar 3, 2025	GDRX GoodRx Holdings, Inc.	Award(A) Restricted Stock Unit	716,479	-	-	Direct
Mar 3, 2025	GDRX GoodRx Holdings, Inc.	Award(A) Stock Option (Right to Buy)	1,096,937	-	-	Direct

1-12 of 12 transactions

About McGinnis Christopher A

McGinnis Christopher A (SEC CIK 0001652479) files insider reports with the SEC as Officer of GoodRx Holdings, Inc. (GDRX).

Signal8 holds 7 ownership filings by McGinnis Christopher A (1 Form 3, 6 Form 4), filed between Feb 5, 2025 and Jul 16, 2026. Those filings report 12 transactions, from Mar 3, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McGinnis Christopher A's filings is in SANTA MONICA, CA.

Recent filings by McGinnis Christopher A

Jul 15, 2026: Option exercise of GDRX shares (Form 4, code M).
Jul 15, 2026: Tax withholding of GDRX shares (Form 4, code F).
May 15, 2026: Option exercise of GDRX shares (Form 4, code M).
May 15, 2026: Tax withholding of GDRX shares (Form 4, code F).
Apr 15, 2026: Option exercise of GDRX derivative securities (Form 4, code M).

Other insiders filing for GoodRx Holdings, Inc. (GDRX)

Bezdek Trevor, Director
Hirsch Douglas Joseph, Director
Fengler Justin
Chan Thomas (TC), Chief Accounting Officer
Barnes Wendy Lynn
FRANCISCO PARTNERS IV, L.P., 10% Owner

How to read Form 4 transaction codes